Mr Charles Pollard Iii, NP - Medicare Nurse Practitioner in Midwest City, OK

Mr Charles Pollard Iii, NP is a medicare enrolled "Nurse Practitioner - Family" in Midwest City, Oklahoma. His current practice location is 6951 Se 15th St, Midwest City, Oklahoma. You can reach out to his office (for appointments etc.) via phone at (405) 233-0450.

Mr Charles Pollard Iii is licensed to practice in Oklahoma (license number 87886) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1497164396.

Contact Information

Mr Charles Pollard Iii, NP
6951 Se 15th St,
Midwest City, OK 73110-2748
(405) 233-0450
Not Available



Provider's Profile

Full NameMr Charles Pollard Iii
GenderMale
SpecialityNurse Practitioner - Family
Location6951 Se 15th St, Midwest City, Oklahoma
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1497164396
  • Provider Enumeration Date: 08/05/2014
  • Last Update Date: 07/07/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 4183942683
  • Enrollment ID: I20150414000120

Medical Identifiers

Medical identifiers for Mr Charles Pollard Iii such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1497164396NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
363LF0000XNurse Practitioner - Family 87886 (Oklahoma)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mr Charles Pollard Iii allows following entities to bill medicare on his behalf.
Entity NameFamily Health Care & Minor Emergency Clinic Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548355134
PECOS PAC ID: 8729075650
Enrollment ID: O20040430000458

News Archive

Largest post-mortem study of SARS deaths teaches scientists about the disease

Led by John Nicholls of Hong Kong University, researchers from Hong Kong and from Toronto (two of the cities worst affected by the 2003 SARS outbreak) joined forces for a large and detailed study of the bodies of 32 patients who had died from SARS.

Griffith University researchers discover critical weakness in leukaemic cells

Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.

University of Alicante develops tool for people with autism spectrum disorders

The University of Alicante has developed, together with centres in the UK, Spain and Bulgaria, a tool designed to assist people with autism spectrum disorders by adapting written documents into a format that is easier for them to read and understand. This is the main result of the three-year project FIRST (A Flexible Interactive Reading Support Tool), funded by the European Commission under the Seventh Framework Programme.

Elevated c-Myc expression amplifies gene activity in tumor cells of multiple cancer types

For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 4 days ago

Entity NameNeighborhood Family Clinic & Minor
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1730304320
PECOS PAC ID: 9234136623
Enrollment ID: O20061027000065

News Archive

Largest post-mortem study of SARS deaths teaches scientists about the disease

Led by John Nicholls of Hong Kong University, researchers from Hong Kong and from Toronto (two of the cities worst affected by the 2003 SARS outbreak) joined forces for a large and detailed study of the bodies of 32 patients who had died from SARS.

Griffith University researchers discover critical weakness in leukaemic cells

Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.

University of Alicante develops tool for people with autism spectrum disorders

The University of Alicante has developed, together with centres in the UK, Spain and Bulgaria, a tool designed to assist people with autism spectrum disorders by adapting written documents into a format that is easier for them to read and understand. This is the main result of the three-year project FIRST (A Flexible Interactive Reading Support Tool), funded by the European Commission under the Seventh Framework Programme.

Elevated c-Myc expression amplifies gene activity in tumor cells of multiple cancer types

For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 4 days ago

Entity NameFhcokc, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144556952
PECOS PAC ID: 7618122177
Enrollment ID: O20130307000059

News Archive

Largest post-mortem study of SARS deaths teaches scientists about the disease

Led by John Nicholls of Hong Kong University, researchers from Hong Kong and from Toronto (two of the cities worst affected by the 2003 SARS outbreak) joined forces for a large and detailed study of the bodies of 32 patients who had died from SARS.

Griffith University researchers discover critical weakness in leukaemic cells

Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.

University of Alicante develops tool for people with autism spectrum disorders

The University of Alicante has developed, together with centres in the UK, Spain and Bulgaria, a tool designed to assist people with autism spectrum disorders by adapting written documents into a format that is easier for them to read and understand. This is the main result of the three-year project FIRST (A Flexible Interactive Reading Support Tool), funded by the European Commission under the Seventh Framework Programme.

Elevated c-Myc expression amplifies gene activity in tumor cells of multiple cancer types

For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 4 days ago

Entity NameMy Family Clinic Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1730565912
PECOS PAC ID: 7517277114
Enrollment ID: O20151111001875

News Archive

Largest post-mortem study of SARS deaths teaches scientists about the disease

Led by John Nicholls of Hong Kong University, researchers from Hong Kong and from Toronto (two of the cities worst affected by the 2003 SARS outbreak) joined forces for a large and detailed study of the bodies of 32 patients who had died from SARS.

Griffith University researchers discover critical weakness in leukaemic cells

Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.

University of Alicante develops tool for people with autism spectrum disorders

The University of Alicante has developed, together with centres in the UK, Spain and Bulgaria, a tool designed to assist people with autism spectrum disorders by adapting written documents into a format that is easier for them to read and understand. This is the main result of the three-year project FIRST (A Flexible Interactive Reading Support Tool), funded by the European Commission under the Seventh Framework Programme.

Elevated c-Myc expression amplifies gene activity in tumor cells of multiple cancer types

For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 4 days ago

Entity NameOak Street Health Physicians Group Of Oklahoma, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538742051
PECOS PAC ID: 1355746769
Enrollment ID: O20210824001241

News Archive

Largest post-mortem study of SARS deaths teaches scientists about the disease

Led by John Nicholls of Hong Kong University, researchers from Hong Kong and from Toronto (two of the cities worst affected by the 2003 SARS outbreak) joined forces for a large and detailed study of the bodies of 32 patients who had died from SARS.

Griffith University researchers discover critical weakness in leukaemic cells

Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.

University of Alicante develops tool for people with autism spectrum disorders

The University of Alicante has developed, together with centres in the UK, Spain and Bulgaria, a tool designed to assist people with autism spectrum disorders by adapting written documents into a format that is easier for them to read and understand. This is the main result of the three-year project FIRST (A Flexible Interactive Reading Support Tool), funded by the European Commission under the Seventh Framework Programme.

Elevated c-Myc expression amplifies gene activity in tumor cells of multiple cancer types

For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 4 days ago

Entity NameArchwell Health Professional Services Of Oklahoma Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457934895
PECOS PAC ID: 6608272638
Enrollment ID: O20210831000931

News Archive

Largest post-mortem study of SARS deaths teaches scientists about the disease

Led by John Nicholls of Hong Kong University, researchers from Hong Kong and from Toronto (two of the cities worst affected by the 2003 SARS outbreak) joined forces for a large and detailed study of the bodies of 32 patients who had died from SARS.

Griffith University researchers discover critical weakness in leukaemic cells

Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.

University of Alicante develops tool for people with autism spectrum disorders

The University of Alicante has developed, together with centres in the UK, Spain and Bulgaria, a tool designed to assist people with autism spectrum disorders by adapting written documents into a format that is easier for them to read and understand. This is the main result of the three-year project FIRST (A Flexible Interactive Reading Support Tool), funded by the European Commission under the Seventh Framework Programme.

Elevated c-Myc expression amplifies gene activity in tumor cells of multiple cancer types

For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Charles Pollard Iii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mr Charles Pollard Iii, NP
102 Woodmont Blvd Ste 600,
Nashville, TN 37205-5250

Ph: (889) 871-1518
Mr Charles Pollard Iii, NP
6951 Se 15th St,
Midwest City, OK 73110-2748

Ph: (405) 233-0450

News Archive

Largest post-mortem study of SARS deaths teaches scientists about the disease

Led by John Nicholls of Hong Kong University, researchers from Hong Kong and from Toronto (two of the cities worst affected by the 2003 SARS outbreak) joined forces for a large and detailed study of the bodies of 32 patients who had died from SARS.

Griffith University researchers discover critical weakness in leukaemic cells

Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.

University of Alicante develops tool for people with autism spectrum disorders

The University of Alicante has developed, together with centres in the UK, Spain and Bulgaria, a tool designed to assist people with autism spectrum disorders by adapting written documents into a format that is easier for them to read and understand. This is the main result of the three-year project FIRST (A Flexible Interactive Reading Support Tool), funded by the European Commission under the Seventh Framework Programme.

Elevated c-Myc expression amplifies gene activity in tumor cells of multiple cancer types

For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more News

› Verified 4 days ago


Nurse Practitioner Nurses in Midwest City, OK

Dr. Karen Daniels Rackley, DNP, APRN CNP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 2825 Parklawn Dr, Midwest City, OK 73110
Phone: 405-610-4411    
Mrs. Venetta Ann Girardi, APRN, NP-C
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 1800 S Douglas Blvd, Midwest City, OK 73130
Phone: 405-733-4985    
Mrs. Heather D Stanley, APRN-CNP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 2801 S Douglas Blvd, Ste 108, Midwest City, OK 73130
Phone: 405-737-3278    Fax: 405-737-0240
Calli Beth Ann Landes, NP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 2825 Parklawn Dr, Midwest City, OK 73110
Phone: 405-610-8993    Fax: 405-610-8127
Ms. Kandy Brown, APRN, NP-C
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 9230 E Reno Ave Ste B, Midwest City, OK 73130
Phone: 405-737-4900    Fax: 405-737-3606
Mrs. Robin N Avery, ARNP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 1800 S Douglas Blvd, Midwest City, OK 73130
Phone: 405-732-7119    Fax: 405-732-7120
Ms. Porsha Lynn Richardson, NURSE PRACTITIONER
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 1117 S Douglas Blvd Ste B, Midwest City, OK 73130
Phone: 405-208-4573    Fax: 405-429-4083

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.